
Colin Weekes
Medical Oncology · Massachusetts General Hospital
Credentials: · · · · · ·
History
Research
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy · 2016 · 4,439 citations
Patient-derived tumour xenografts as models for oncology drug development
Review · Nature Reviews Clinical Oncology · 2012 · 1,030 citations
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 795 citations
- JC
24 papers

24 papers

24 papers

22 papers
- AP
21 papers
- JA
20 papers
- LB
19 papers

16 papers
Clinical trials
- 2022–2023
FOLFIRINOX + NIS793 in Pancreatic Cancer
Principal investigator · Terminated · Phase 1
Colin D. Weekes, M.D., PhD
- 2022–2026
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
Principal investigator · Active not recruiting · Phase 2
Colin D. Weekes, M.D., PhD
- 2013–2017
Principal investigator · Completed · Phase 1
OncoMed Pharmaceuticals, Inc.




